This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n20http://localhost/temp/predkladatel/
n13http://linked.opendata.cz/resource/domain/vavai/projekt/
n4http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n9http://linked.opendata.cz/resource/domain/vavai/subjekt/
n8http://linked.opendata.cz/ontology/domain/vavai/
n16http://linked.opendata.cz/resource/domain/vavai/zamer/
n15http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216224%3A14110%2F12%3A00057708%21RIV13-GA0-14110___/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n19http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n21http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n18http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216224%3A14110%2F12%3A00057708%21RIV13-GA0-14110___
rdf:type
skos:Concept n8:Vysledek
dcterms:description
The introduction of novel drugs (thalidomide, lenalidomide [immunomodulatory drugs; IMiDs] and bortezomib) optimistically changed the outcome of patients with multiple myeloma (MM) in terms of progressionfree and overall survival when compared to conventional chemotherapies. The introduction of novel drugs (thalidomide, lenalidomide [immunomodulatory drugs; IMiDs] and bortezomib) optimistically changed the outcome of patients with multiple myeloma (MM) in terms of progressionfree and overall survival when compared to conventional chemotherapies.
dcterms:title
Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma
skos:prefLabel
Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma
skos:notation
RIV/00216224:14110/12:00057708!RIV13-GA0-14110___
n8:predkladatel
n9:orjk%3A14110
n3:aktivita
n10:Z n10:P
n3:aktivity
P(GAP304/10/1395), P(LC06027), P(NS10406), P(NS10408), Z(MSM0021622434)
n3:cisloPeriodika
7
n3:dodaniDat
n18:2013
n3:domaciTvurceVysledku
n4:9622748 n4:4954130 n4:3042642
n3:druhVysledku
n21:J
n3:duvernostUdaju
n7:S
n3:entitaPredkladatele
n15:predkladatel
n3:idSjednocenehoVysledku
141238
n3:idVysledku
RIV/00216224:14110/12:00057708
n3:jazykVysledku
n17:eng
n3:klicovaSlova
lenalidomide; dexamethasone; multiple myeloma
n3:klicoveSlovo
n14:dexamethasone n14:multiple%20myeloma n14:lenalidomide
n3:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n3:kontrolniKodProRIV
[3CF914261A98]
n3:nazevZdroje
Leukemia & Lymphoma
n3:obor
n6:FD
n3:pocetDomacichTvurcuVysledku
3
n3:pocetTvurcuVysledku
3
n3:projekt
n13:LC06027 n13:GAP304%2F10%2F1395 n13:NS10406 n13:NS10408
n3:rokUplatneniVysledku
n18:2012
n3:svazekPeriodika
53
n3:tvurceVysledku
Hájek, Roman Muthu Raja, Karthick Raja Říhová, Lucie
n3:wos
000305480100027
n3:zamer
n16:MSM0021622434
s:issn
1042-8194
s:numberOfPages
3
n19:doi
10.3109/10428194.2011.652106
n20:organizacniJednotka
14110